Sec Form 13G Filing - Alon Silberman filing for - 2025-10-28

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Alon Silberman is an individual and the Chief Executive Officer of MitoCareX Bio Ltd., a wholly owned subsidiary of the Issuer. The 454,127 shares of common stock, par value $0.0001 per share ("Common Stock"), beneficially owned by the Reporting Person were acquired as part of the Securities Purchase and Exchange Agreement, as amended, dated February 25, 2025. Percentage of class represented in Row 11 is based on 2,682,483 shares of Common Stock issued and outstanding as of the date of this Schedule 13G, according to information provided by the Issuer.


SCHEDULE 13G


 
Alon Silberman
 
Signature:/s/Alon Silberman
Name/Title:Dr. Alon Silberman
Date:10/28/2025
primary_doc.xml